United States G-Protein Coupled Receptor (GPCR) Targeting Market 2025 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

G-protein Coupled Receptor (GPCR) Targeting Market is Expected to reach at a high CAGR of 6.40% during the forecast period (2024-2031).

Key Development:

United States: Recent Developments in GPCR Targeting

✅ In August 2025, Nxera Pharma announced the launch of an expanded drug discovery pipeline targeting obesity and related metabolic diseases. The company is focusing on a range of validated GPCR targets, building on existing collaborations with Pfizer and Eli Lilly.

✅ In July 2025, Confo Therapeutics revealed advancements in its proprietary technology aimed at targeting GPCR conformational changes. This approach opens new therapeutic avenues for treating cancer and neurological diseases.

✅ In June 2025, Tectonic Therapeutics announced the development of innovative platforms for discovering drugs targeting GPCRs involved in immune and inflammatory diseases, with a focus on immune modulation.

Japan: Recent Developments in GPCR Targeting

✅ In September 2025, the Japan Entry Acceleration Program (JEAP) 2025 was launched to support innovative health startups in regenerative medicine and gene therapy for their entry into the Japanese market. The program offers personalized support, strategic networking, and a Demo Day in Tokyo.

✅ In August 2025, Nxera Pharma, based in Tokyo, launched an expanded drug discovery pipeline targeting obesity and related metabolic diseases. The company's efforts build on independent research in addition to existing collaborations with Pfizer and Eli Lilly, focusing on a range of validated GPCR targets.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/g-protein-coupled-receptor-targeting-market?sb

Recent Mergers and acquisitions:

United States: Recent M&A in GPCR Targeting

✅ In January 2025, Exicure Inc. acquired GPCR Therapeutics Inc.'s U.S. subsidiary, GPCR Therapeutics USA Inc. This acquisition brings burixafor (GPC-100), a selective CXCR4 antagonist, into Exicure's pipeline, enhancing its focus on immuno-oncology and regenerative medicine.

✅ In May 2025, Novo Nordisk entered into a partnership with California-based Septerna, potentially worth up to $2.2 billion. The collaboration aims to develop up to four new obesity drugs targeting GPCRs, including GLP-1, GIP, and glucagon receptors.

✅ In October 2025, AstraZeneca signed a licensing agreement with U.S.-based Algen Biotechnologies valued at up to $555 million. The deal focuses on developing gene therapies for immune system-related disorders, leveraging Algen's AI-driven platform, AlgenBrain, to map genes to disease outcomes.

Key Players:

=> Abcam plc, Enzo Life Sciences, Inc, Promega Corporation, PerkinElmer Inc, Thermo Fisher Scientific, Eurofins DiscoverX Products, WuXi AppTec (HD Biosciences Co. Ltd), BioInvenu Inc, Danaher Corporation (Molecular Devices LLC) and Merck KGaA.

Growth Forecast Projected:

The Global G-protein Coupled Receptor (GPCR) Targeting Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global G-protein Coupled Receptor (GPCR) Targeting Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=g-protein-coupled-receptor-targeting-market

Key Segments:

➥ By Product: Cell Lines, Detection Kits, Cell Culture Reagents, Ligands

➥ By Application Segment: Cancer Research, CNS Research, Metabolic Research, Cardiovascular Research, Respiratory Research, Inflammation Research, Other Application

➥ By End-User: cAMP Functional Assays, Calcium Functional Assays, β-Arrestin Functional Assays, Radioligand Binding and GTPγS Functional Assays, Internalization Assays, Trafficking Assays, Other Assays

Regional Analysis for G-protein Coupled Receptor (GPCR) Targeting Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among G-protein Coupled Receptor (GPCR) Targeting producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze G-protein Coupled Receptor (GPCR) Targeting revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/g-protein-coupled-receptor-targeting-market?sb

FAQ

Q: What is the growth rate of the G-protein Coupled Receptor (GPCR) Targeting Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 6.40% during the forecast period from 2024 to 2031.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.